NMDA-GABA interactions in an animal model of behaviour: a gating mechanism from motivation toward psychotic-like symptoms
- 30 June 1994
- journal article
- Published by Elsevier BV in European Neuropsychopharmacology
- Vol. 4 (2), 103-109
- https://doi.org/10.1016/0924-977x(94)90003-5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Antidepressant and anxiolytic effects of alprazolam versus the conventional. antidepressant desipramine and the anxiolytic diazepam in the forced swim test in ratsEuropean Journal of Pharmacology, 1992
- Distribution of beta‐adrenergic receptor subtypes in human post‐mortem brain: Alterations in limbic regions of schizophrenicsSynapse, 1992
- Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's diseaseTrends in Neurosciences, 1990
- Does kindling model anything clinically relevant?Biological Psychiatry, 1990
- Substantia nigra-mediated anticonvulsant actions: Role of nigral output pathwaysExperimental Neurology, 1987
- Anticonvulsant action of 2-amino-7-phosphonoheptanoic acid in the substantia nigraEuropean Journal of Pharmacology, 1984
- Evidence that the nigrotegmental GABAergic projection mediates stereotypy induced by apomorphine and intranigral muscimolLife Sciences, 1983
- Crossed connections of the substantia nigra in the ratJournal of Comparative Neurology, 1982
- Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo [a, d]cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic propertiesDrug Development Research, 1982
- The influence of striatal stimulation and putative neurotransmitters on identified neurones in the rat substantia nigraBrain Research, 1981